Impact of Chronic Kidney Disease on Severity and Mortality in COVID-19 Patients: A Systematic Review and Meta-analysisInternal Medicine Published on 2021-04-032022-10-31 Journal: Cureus [Category] COVID-19, [키워드] 95% CI 95% confidence interval affected Analysis article articles association chronic Chronic kidney disease chronic renal disease CKD clinical Cohort cohorts collaboration conducted coronavirus disease 19 COVID-19 COVID-19 patient Critically ill death died Evidence Google Scholar Impact inclusion criteria increased risk initial search involved male manifested median age Meta-analysis Mortality New Odds ratio Patient patients Prevalence Prognosis programming protocol provided reported resulting review risk SARS-CoV-2 severe COVID-19 severe disease severity of COVID-19 significantly increased the disease underlying disease university worse prognosis [DOI] 10.7759/cureus.14279 PMC 바로가기 [Article Type] Internal Medicine
Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAEObservational Study Published on 2021-03-012022-10-04 Journal: BioMed Research International [Category] 임상, [키워드] Abu Afghanistan age approved Asia Asian average cardiovascular disease chronic renal disease city Cluster Comorbidity correlated COVID COVID-19 death Deceased Department diabetes died disease Duration enrolled Ethnicity groups Gulf higher risk highest Hospitalization hypertension identify Impact increased risk India Levant Liver disease males malignancy men Mortality Nepal North Older older patient outcome Patient patients hospitalized Prognosis public health reached Record reported required Result returned risk Sex significantly South statistical significance survivor the disease those with comorbidities understanding with COVID-19 Wuhan [DOI] 10.1155/2021/6695707 PMC 바로가기 [Article Type] Observational Study
Impact of Ethnicity and Underlying Comorbidity on COVID-19 Inhospital Mortality: An Observational Study in Abu Dhabi, UAEObservational Study Published on 2021-03-012022-10-27 Journal: BioMed Research International [Category] COVID-19, MERS, [키워드] Abu Afghanistan age approved Asia Asian average cardiovascular disease chronic renal disease city Cluster Comorbidity correlated COVID COVID-19 death Deceased Department diabetes died disease Duration enrolled Ethnicity groups Gulf higher risk highest Hospitalization hypertension identify Impact increased risk India Levant Liver disease males malignancy men Mortality Nepal North Older older patient outcome Patient patients hospitalized Prognosis public health reached Record reported required Result returned risk Sex significantly South statistical significance survivor the disease those with comorbidities understanding with COVID-19 Wuhan [DOI] 10.1155/2021/6695707 PMC 바로가기 [Article Type] Observational Study
[Recommendations for the management of the patient with chronic renal disease with SARS-CoV-2][SARS-CoV-2 만성신질환자 관리를 위한 권고사항]Case Reports Published on 2021-02-012022-09-11 Journal: Enferm Clin [Category] SARS, 치료기술, [키워드] advanced age Affect Chronic kidney disease chronic renal disease clinical Clinical protocols Contagion COVID-19 distribution English epidemia Factors Health Hemodialysis Hemodialysis, Kidney transplantation Immunosuppression include initial initial stage Isolation Kidney disease Kidney diseases management measure more difficult Pandemia para Patient professional professionals protocol protocols renal renal disease risk SARS-CoV-2 SARS-CoV-2 pandemic Spanish Stage suffering technique the epidemic the patient transfer [DOI] 10.1016/j.enfcli.2020.05.017 PMC 바로가기 [Article Type] Case Reports
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)입원한 COVID-19 환자의 중증 SARS-CoV-2 감염 예방을 위한 재조합 인간 C1 에스테라제 억제제(conestat alfa): 무작위, 병렬 그룹, 공개 라벨, 다중 센터에 대한 연구 프로토콜의 구조화된 요약 파일럿 시험(PROTECT-COVID-19)Letter Published on 2021-01-042022-09-10 Journal: Trials [Category] 임상, [키워드] 24 hour 24 hours Activation activities acute lung injury addition adjusted Administered administration allergy Antibiotics anticipated anticoagulation arterial Arterial hypertension Basel Blinding BMI Brazil Breast Breast feeding breathing ambient air C-reactive protein C1 esterase inhibitor cardiovascular disease Caregivers changes in Chest Child-Pugh score chronic chronic pulmonary disease chronic renal disease cirrhosis class clinical Clinical improvement clinical trial comparator comparator Patients complement complement system completion conducted Conestat alfa Contact contact activation system contraindication control group Corticosteroids COVID-19 COVID-19 patient CT scan death defined discharge disease disease severity dissemination drug Duration Efficacy and safety element eligibility enrolment evidence of experimental arm family members FIVE followed by history hospital Hospitalization hospitalized patient hypertension ICU IL-6 inhibitor IL-6R improvement Incapacity include inclusion criteria individual Infection inflammatory cascade inflammatory cascades inflammatory proteins inhibitor Interactive Web Response System interim analysis Intravenous injection invasive invasive or non-invasive ventilation investigator-initiated investigators kallikrein kinin system laboratory parameter Liver cirrhosis Local Lung injury mechanical ventilation non-invasive ventilation not blinded number obesity objective Open-label open-label trial Ordinal Scale outcome outcome assessor outcome assessors oxygen oxygen saturation pandemic PaO parallel-group participant Participants Participation Patient performed Pregnancy primary endpoint progression proportion protocol pulmonary disease pulmonary involvement randomised randomization Randomized randomized trial receive recombinant recruited recruitment Registered Remdesivir renal renal disease required risk factor Sample size SARS-COV-2 infection SARS-CoV-2 pandemic scale screened secondary Secondary outcomes severe COVID-19 severe SARS-CoV-2 Standard of care status Study protocol subject supplemental oxygen supplementary material suspicion Switzerland Symptom the SARS-CoV-2 the WHO their family members Tocilizumab Treatment treatment arm Trial Two interim analyses Two interim analysis virological clearance website WHO WHO ordinal scale with COVID-19 X-ray [DOI] 10.1186/s13063-020-04976-x PMC 바로가기 [Article Type] Letter
The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020Surveillance Published on 2020-12-172022-10-31 Journal: Eurosurveillance [Category] COVID-19, MERS, SARS, [키워드] 95% confidence interval Admission admitted to ICU affected cardiovascular category characterisation Characteristics chronic renal disease condition coronavirus disease COVID-19 COVID-19 case COVID-19 cases COVID-19 pandemic death declining died disease disease severity enhanced Epidemic females First wave HCWs healthcare worker higher odd higher risk highest hospitalisation hospitalised ICU identify intensive care lockdown measure multivariable National Odds ratio outcome outcomes pandemic PCR-confirmed peaked Pneumonia proportion renal reported Result risk factor Risk factors SARS-CoV-2 severity Spain Spread subgroup Surveillance surveillance data underlying disease underlying diseases were used [DOI] 10.2807/1560-7917.ES.2020.25.50.2001431 PMC 바로가기 [Article Type] Surveillance
Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational studyResearch Published on 2020-10-062022-10-28 Journal: Annals of Intensive Care [Category] COVID-19, [키워드] Acute kidney injury acute respiratory distress age analyzed Antiviral antiviral strategy antiviral therapy Antiviral treatment ARDS ARDS patients benefit BMI Charlson Comorbidity Index chronic renal disease cohort of patient Combination COVID-19 dead dichotomized died Efficacy French group highest Hydroxychloroquine hypertension ICU ICU patient incidence increased risk insight intensive care unit Invasive mechanical ventilation IQR Kidney injury Limited linear mixed model Lopinavir mechanical ventilation median multicentre observé other treatments outcome PaO Patient patients treated primary endpoint receiving Remdesivir renal replacement therapy Result Ritonavir RRT Severe patient Sex Standard of care syndrome treated Treatment Ventilated ventilator-free day VFD [DOI] 10.1186/s13613-020-00751-y PMC 바로가기 [Article Type] Research
The Impact of SARS-CoV-2 on the Most Common Comorbidities–A Retrospective Study on 814 COVID-19 Deaths in RomaniaMedicine Published on 2020-09-092022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] 95% CI affecting age analyzed calculated Cancer caused chronic liver disease chronic pulmonary disease chronic renal disease common Comorbidity condition COPD Coronary heart disease coronavirus COVID-19 death demographics diabete diabetes died disease General population greater hypertension Impact male medium Ministry of Health MOST most prevalent comorbidities most prevalent comorbidity occurred Prevalence reported risk risk of death Romania SARS-CoV-2 SARS-CoV2 infection seeking shielding Spread stroke the mean the patient Treatment underlying conditions underlying diseases vaccination was used WHO [DOI] 10.3389/fmed.2020.567199 PMC 바로가기 [Article Type] Medicine
SARS‐CoV‐2 infection associated acute kidney injury in patients with pre‐existing chronic renal disease: A report of two casesOriginal Research Published on 2020-07-282022-10-30 Journal: Immunity, Inflammation and Disease [Category] COVID-19, MERS, SARS, [키워드] 2019 novel coronavirus Acute kidney injury acute respiratory syndrome aggravate Atypical change China Chronic kidney disease chronic renal disease Clinical characteristics Computed tomography consolidation coronavirus coronavirus disease coronavirus nucleic acid COVID‐19 COVID‐19 patient COVID‐19 criteria described diagnosed discharge driving dry cough female Fever impairment Infection information Intervention Kidney disease Limited lobe male MONITOR outbreak outcome patchy Patient patients Pneumonia positive Prognosis prognosis of patient public health renal renal function restored SARS‐CoV‐2 infection SARS‐CoV‐2 Shortness of breath Support symptomatic Thorax throat swab Treatment Wuhan [DOI] 10.1002/iid3.333 PMC 바로가기 [Article Type] Original Research
Emerging Roles of IL-33/ST2 Axis in Renal DiseasesReview Published on 2017-04-072023-08-30 Journal: International Journal of Molecular Sciences [Category] E형 간염, [키워드] acute renal injury chronic renal disease Inflammation interleukin-33 [DOI] 10.3390/ijms18040783 PMC 바로가기 [Article Type] Review